CCA
AEON.WS

Castle Creek Arbitrage’s AEON Biopharma Inc AEON.WS Stock Holding History

Castle Creek Arbitrage’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-82,524
Closed -$13.2K – 177
2023
Q3 		$13.2K Sell
82,524
-2,532
-3% -$359 ﹤0.01% 162
2023
Q2 		$7.23K Hold
85,056
– – ﹤0.01% 298
2023
Q1 		$4.68K Hold
85,056
– – ﹤0.01% 409
2022
Q4 		$3.19K Hold
85,056
– – ﹤0.01% 462
2022
Q3 		$6K Hold
85,056
– – ﹤0.01% 582
2022
Q2 		$13K Hold
85,056
– – ﹤0.01% 555
2022
Q1 		$26K Hold
85,056
– – ﹤0.01% 579
2021
Q4 		$43K Hold
85,056
– – ﹤0.01% 612
2021
Q3 		$49K Hold
85,056
– – ﹤0.01% 568
2021
Q2 		$85K Buy
+85,056
New +$64.6K ﹤0.01% 560

Other funds holding AEON.WS

AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Castle Creek Arbitrage's AEON.WS Position: Q4 2023 in Review

Castle Creek Arbitrage sold out of AEON Biopharma Inc (AEON.WS) in Q4 2023, closing a stake of 82,524 shares — an estimated $13.2K sold.

Castle Creek Arbitrage first reported a position in AEON.WS in Q2 2021 and held it in 10 quarters. The position peaked at $85K in Q2 2021. 40 funds tracked by Wall St. Rank hold AEON.WS as of Q4 2023.

  • Castle Creek Arbitrage reported no remaining AEON Biopharma Inc position as of Q4 2023 after selling out during the quarter.
  • Castle Creek Arbitrage sold 82,524 AEON Biopharma Inc shares in Q4 2023, an estimated $13.2K.
  • Castle Creek Arbitrage first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 10 quarters.
  • Castle Creek Arbitrage's AEON Biopharma Inc position peaked at $85K in Q2 2021.
  • 40 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q4 2023.

Based on Castle Creek Arbitrage's 13F filing for Q4 2023.